CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

autologous cd34+ cells

Cell therapyexperimental

Clinical trial activity

51 trials · 63 clinical orgs · 0 marketing orgs

Phase 1
26
Phase 2
28
Phase 3
3
Phase 4
0

Earliest trial started Dec 3, 1993 (NCT00001399)

Timeline

1990s

  1. Jan 1, 1993

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 1998

    Earliest Phase 2 Sponsor(trial)

2010s

  1. Jan 1, 2012

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

  • Stem CellTissue restoration

    Stem Cell tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • autologous cd34+ cells
  • autologous cd34+ cells genetically modified
  • autologous cd34+hpc stem cells
  • autologous cd34 positive cells
  • autologous cd34-positive stem cells
  • autologous cd34+ stem cells
  • autologous expanded cd34+ haemopoietic cells
  • autologous pb-cd34+ stem cells
  • blood forming stem cell (cd34+cd90+)
  • cd34+ autologous stem cell
  • cd34+ bone marrow stem cells
  • cd34+ cells
  • cd34 enriched stem cell
  • cd34+ peripheral blood stem cell
  • cd34-positive cells
  • cd34-selected peripheral blood stem cell
  • cd34 selected progenitor cells
  • dli
  • gene-modified cd34+ hematopoietic stem cells
  • gene-transduced autologous cd34+ stem cells
  • transduced cd34+ hematopoietic stem cell

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06253507Phase 1/Phase 2 (Phase 2)Jun 25, 2024National Institute of Allergy and Infectious Diseases (NIAID)
NCT05507827Phase 1Aug 18, 2022Orca Biosystems, Inc., Stanford University
NCT05088356Phase 1Sep 7, 2021Orca Biosystems, Inc., Stanford University
NCT04925687Phase 1Jun 1, 2021Cures Within Reach, University of California, Davis
NCT04614467Phase 2Oct 28, 2020Caladrius Biosciences
NCT04522817Phase 1Oct 5, 2020Caladrius Biosciences
NCT03970096Phase 2Jul 6, 2019National Cancer Institute (NCI), University of Washington
NCT03981549Phase 1/Phase 2 (Phase 2)Jun 30, 2019National Eye Institute (NEI), The EMMES Corporation, University of California, Davis
NCT03605654Phase 2/Phase 3 (Phase 3)Dec 31, 2018Medeor Therapeutics, Inc.
NCT04198883Phase 1/Phase 2 (Phase 2)Nov 27, 2018CellProthera
NCT03471611Phase 1May 1, 2018Mayo Clinic
NCT03483324Phase 1Apr 24, 2018Angiocrine Bioscience, Memorial Sloan-Kettering Cancer Center
NCT03508609Phase 2Apr 19, 2018Caladrius Biosciences, Cedars-Sinai Medical Center, Mayo Clinic, National Heart, Lung, and Blood Institute (NHLBI), University of California, San Francisco
NCT03276455Phase 1/Phase 2 (Phase 2)Sep 15, 2017Guangdong Yike Gene Science and Technology CO.,Ltd, Southern Medical University
NCT02963064Phase 1Aug 1, 2016California Institute for Regenerative Medicine, Stanford University, University of California, San Francisco
NCT02669810Phase 2Oct 1, 2015CellProthera
NCT02345850Phase 3Aug 1, 2015Blood and Marrow Transplant Clinical Trials Network, Center for International Blood and Marrow Transplant Research, National Cancer Institute (NCI), National Heart, Lung, and Blood Institute (NHLBI)
NCT02438904N/AMay 1, 2015University of Texas at Houston
NCT02371434Phase 1/Phase 2 (Phase 2)Jan 1, 2015Humboldt University
NCT02559830Phase 1/Phase 2 (Phase 2)Jan 1, 2015China Medical University, Guangzhou Medical University, Shenzhen University, The University of Hong Kong
Showing 20 of 51 trials
Page 1 / 3

Organizations

Research & Development (63)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Northwestern UniversityAcademic/Hospital6422001
National Heart, Lung, and Blood Institute (NHLBI)Government4241993
National Institute of Allergy and Infectious Diseases (NIAID)Government4422001
Stanford UniversityAcademic/Hospital4322006
University of California, San FranciscoAcademic/Hospital4132010
Caladrius BiosciencesFor profit3322018
National Cancer Institute (NCI)Government3122001
University of California, DavisAcademic/Hospital3222012
BaxaltaFor profit2122007
CellProtheraFor profit2212015
Columbia UniversityAcademic/Hospital2122005
Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y MielodisplasiasAcademic/Hospital2211998
Mayo ClinicAcademic/Hospital2122018
Miltenyi Biotec, Inc.For profit2012011
Orca Biosystems, Inc.For profit2012021
University of BarcelonaAcademic/Hospital2011998
University of California, Los AngelesAcademic/Hospital2012005
University of LondonAcademic/Hospital2222006
University of Texas at HoustonAcademic/Hospital2222001
Angiocrine BioscienceFor profit1112018
63 organizations
Page 1 / 4